Literature DB >> 10212280

Effects of overexpression of PTP36, a putative protein tyrosine phosphatase, on cell adhesion, cell growth, and cytoskeletons in HeLa cells.

M Ogata1, T Takada, Y Mori, M Oh-hora, Y Uchida, A Kosugi, K Miyake, T Hamaoka.   

Abstract

Non-receptor-type putative protein tyrosine phosphatase-36 (PTP36), also known as PTPD2/Pez, possesses a domain homologous to the N-terminal half of band 4.1 protein. To gain insight into the biological function of PTP36, we established a HeLa cell line, HtTA/P36-9, in which the overexpression of PTP36 was inducible. PTP36 expressed in HeLa cells was enriched in the cytoskeleton near the plasma membrane. There was little endogenous PTP36 detectable in uninduced HtTA/P36-9 cells or in the parental HeLa cells. Upon induction of PTP36 overexpression, HtTA/P36-9 cells spread less well, grew more slowly, and adhered to the extracellular matrix proteins less well than uninduced cells. Moreover, decreases in the actin stress fibers and the number of focal adhesions were observed. The tyrosine phosphorylation of the focal adhesion kinase induced by lysophosphatidic acid was suppressed in the HtTA/P36-9 cells overexpressing PTP36. These results indicate that PTP36 affects cytoskeletons, cell adhesion, and cell growth, thus suggesting that PTP36 is involved in their regulatory processes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212280     DOI: 10.1074/jbc.274.18.12905

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

2.  PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

Authors:  Jaewoo Choi; Anita Saraf; Laurence Florens; Michael P Washburn; Luca Busino
Journal:  Cell Cycle       Date:  2018-09-25       Impact factor: 4.534

3.  Protein tyrosine phosphatase non-receptor type 14 is a novel sperm-motility biomarker.

Authors:  Hsin-Chih Albert Chao; Chia-Ling Chung; Hsien-An Pan; Pao-Chi Liao; Pao-Lin Kuo; Chao-Chin Hsu
Journal:  J Assist Reprod Genet       Date:  2011-06-24       Impact factor: 3.412

4.  The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.

Authors:  Anita Szalmás; Vjekoslav Tomaić; Om Basukala; Paola Massimi; Suruchi Mittal; József Kónya; Lawrence Banks
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

5.  Customized Array Comparative Genomic Hybridization Analysis of 25 Phosphatase-encoding Genes in Colorectal Cancer Tissues.

Authors:  Izabela Laczmanska; Pawel Skiba; Pawel Karpinski; Marek Bebenek; Maria M Sasiadek
Journal:  Cancer Genomics Proteomics       Date:  2017-01-02       Impact factor: 4.069

6.  PTPN14 interacts with and negatively regulates the oncogenic function of YAP.

Authors:  X Liu; N Yang; S A Figel; K E Wilson; C D Morrison; I H Gelman; J Zhang
Journal:  Oncogene       Date:  2012-04-23       Impact factor: 9.867

7.  Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans.

Authors:  Audrey C Au; Paolo A Hernandez; Ernest Lieber; Ali M Nadroo; Yu-Ming Shen; Kevin A Kelley; Bruce D Gelb; George A Diaz
Journal:  Am J Hum Genet       Date:  2010-09-10       Impact factor: 11.025

8.  Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.

Authors:  Esteban Ballestar; Maria F Paz; Laura Valle; Susan Wei; Mario F Fraga; Jesus Espada; Juan Cruz Cigudosa; Tim Hui-Ming Huang; Manel Esteller
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

9.  PTPN14 is required for the density-dependent control of YAP1.

Authors:  Wenqi Wang; Jun Huang; Xin Wang; Jingsong Yuan; Xu Li; Lin Feng; Jae-Il Park; Junjie Chen
Journal:  Genes Dev       Date:  2012-09-01       Impact factor: 11.361

10.  Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14.

Authors:  P Zhang; A Guo; A Possemato; C Wang; L Beard; C Carlin; S D Markowitz; R D Polakiewicz; Z Wang
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.